Should HDL cholesterol levels be the primary target of cardiovascular disease risk assessment and therapy?
Avishay
A
Elis
D002318:Cardiovascular Diseases / Q000503:physiopathology / Q000517:prevention & control*; D008076:Cholesterol, HDL / Q000097:blood*; D050171:Dyslipidemias / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use; D018570:Risk Assessment
D008076:Cholesterol, HDL; D000960:Hypolipidemic Agents